295 related articles for article (PubMed ID: 29605865)
1. Intratympanic steroid use for idiopathic sudden sensorineural hearing loss: current otolaryngology practice in Germany and Austria.
Sutton L; Schartinger V; Url C; Schmutzhard J; Lechner D; Kavasogullari C; Sandhu JS; Shaida A; Laszig R; Loehler J; Plontke S; Riechelmann H; Lechner M
Eur Arch Otorhinolaryngol; 2018 May; 275(5):1103-1110. PubMed ID: 29605865
[TBL] [Abstract][Full Text] [Related]
2. Intratympanic Steroid Use for Sudden Sensorineural Hearing Loss: Current Otolaryngology Practice.
Lechner M; Sutton L; Ferguson M; Abbas Y; Sandhu J; Shaida A
Ann Otol Rhinol Laryngol; 2019 Jun; 128(6):490-502. PubMed ID: 30770021
[TBL] [Abstract][Full Text] [Related]
3. Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexamethasone.
Hobson CE; Alexander TH; Harris JP
Curr Opin Otolaryngol Head Neck Surg; 2016 Oct; 24(5):407-12. PubMed ID: 27379547
[TBL] [Abstract][Full Text] [Related]
4. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy.
Haynes DS; O'Malley M; Cohen S; Watford K; Labadie RF
Laryngoscope; 2007 Jan; 117(1):3-15. PubMed ID: 17202923
[TBL] [Abstract][Full Text] [Related]
5. Steroid Administration Approach for Idiopathic Sudden Sensorineural Hearing Loss: A National Survey in China.
Yao Q; Jiang Z; Zhang J; Huang S; He S; Feng Y; Wang H; Yin S
Ann Otol Rhinol Laryngol; 2021 Jul; 130(7):752-759. PubMed ID: 33185127
[TBL] [Abstract][Full Text] [Related]
6. Intratympanic Triamcinolone Acetonide as Treatment Option for Idiopathic Sudden Sensorineural Hearing Loss.
Dahm V; Nieratschker M; Riss D; Kaider A; Auinger A; Honeder C; Arnoldner C
Otol Neurotol; 2019 Jul; 40(6):720-727. PubMed ID: 31192900
[TBL] [Abstract][Full Text] [Related]
7. Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Ménière's-associated sudden sensorineural hearing loss.
Selivanova OA; Gouveris H; Victor A; Amedee RG; Mann W
Otol Neurotol; 2005 Sep; 26(5):890-5. PubMed ID: 16151334
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic.
Tsuda T; Hanada Y; Wada K; Fujiwara E; Takeda K; Nishimura H
Ear Nose Throat J; 2023 Dec; 102(12):772-779. PubMed ID: 34247535
[TBL] [Abstract][Full Text] [Related]
9. Nationwide Survey of Intratympanic Steroids for the Management of Sudden Sensorineural Hearing Loss.
Levy E; Sela E; Letichevsky V; Ronen O
Isr Med Assoc J; 2019 Feb; 21(2):105-109. PubMed ID: 30772961
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous versus subsequent intratympanic dexamethasone for idiopathic sudden sensorineural hearing loss.
Park MK; Lee CK; Park KH; Lee JD; Lee CG; Lee BD
Otolaryngol Head Neck Surg; 2011 Dec; 145(6):1016-21. PubMed ID: 21817157
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of intratympanic steroid injection in addition to systemic corticosteroids in the treatment of idiopathic sudden sensorineural hearing loss.
Chrysouli K; Kollia P; Papanikolaou V; Chrysovergis A
Am J Otolaryngol; 2023; 44(4):103872. PubMed ID: 37060782
[TBL] [Abstract][Full Text] [Related]
12. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy.
Gouveris H; Selivanova O; Mann W
Eur Arch Otorhinolaryngol; 2005 Feb; 262(2):131-4. PubMed ID: 15747106
[TBL] [Abstract][Full Text] [Related]
13. Intratympanic steroids as a salvage therapy for severe to profound idiopathic sudden sensorineural hearing loss.
Covelli E; Altabaa K; Verillaud B; Camous D; Hautefort C; Barbara M; Herman P; Kania R
Acta Otolaryngol; 2018 Nov; 138(11):966-971. PubMed ID: 30380957
[TBL] [Abstract][Full Text] [Related]
14. Combined intratympanic and systemic use of steroids for idiopathic sudden sensorineural hearing loss: a meta-analysis.
Gao Y; Liu D
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3699-3711. PubMed ID: 27071771
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 and 4 Intratympanic Steroid Injections in the Treatment of Idiopathic Sudden Sensorineural Hearing Loss.
Suzuki H; Wakasugi T; Kitamura T; Koizumi H; Do BH; Ohbuchi T
Ann Otol Rhinol Laryngol; 2018 Apr; 127(4):235-240. PubMed ID: 29411622
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous versus Sequential Intratympanic Steroid Treatment for Severe-to-Profound Sudden Sensorineural Hearing Loss.
Yoo MH; Lim WS; Park JH; Kwon JK; Lee TH; An YH; Kim YJ; Kim JY; Lim HW; Park HJ
Audiol Neurootol; 2016; 21(6):399-405. PubMed ID: 28384627
[TBL] [Abstract][Full Text] [Related]
17. Intratympanic methylprednisolone administration promotes the recovery of idiopathic sudden sensorineural hearing loss: a retrospective case-control study.
Jiang K; Li S; Cheng L; Yang J
Acta Otolaryngol; 2018 Nov; 138(11):998-1003. PubMed ID: 30465620
[TBL] [Abstract][Full Text] [Related]
18. Hearing outcome does not depend on the interval of intratympanic steroid administration in idiopathic sudden sensorineural hearing loss.
Suzuki H; Koizumi H; Ohkubo J; Hohchi N; Ikezaki S; Kitamura T
Eur Arch Otorhinolaryngol; 2016 Oct; 273(10):3101-7. PubMed ID: 26879994
[TBL] [Abstract][Full Text] [Related]
19. Management of Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) Intratympanic Platelet-Rich Plasma (PRP) Versus Intratympanic Steroid Injections: A Cross-Sectional Study.
Shawky M
Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808642
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone eardrop with grommet placement vs intratympanic steroid injection for sudden sensorineural hearing loss: A randomized prospective clinical trial.
Chang WT; Zee B; Lee HSH; Tong MCF
Am J Otolaryngol; 2020; 41(4):102515. PubMed ID: 32487334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
